Overview
Sterility testing confirms the absence of viable microorganisms in injectable and research peptide preparations under USP 71. This panel is essential for release decisions on parenteral research material and pairs naturally with our endotoxin assay on a single shared vial.
- USP 71 method
- Injectable preparations
- Research peptide prep
- Shared vial with endotoxins
Method
USP 71 compliance
Testing performed under controlled environmental monitoring with documented incubation and observation intervals.
Sample suitability
Intake review confirms volume and matrix compatibility before method assignment.
Result interpretation
Pass / fail reported with observation notes and reference to the compendial method.
Specimen
- Sterile, sealed vial with compound name and batch reference on the label.
- Liquid or reconstituted preparation suitable for USP 71 intake volume.
- When combined with endotoxins, one vial covers both panels.
- Do not open vial after labeling; ship with generated order barcode inside the package.
Reporting
- COA with USP 71 method citation
- Pass / fail determination
- Incubation summary
- Sample accession identifiers tied to your order
FAQ
- Do I need a separate vial for sterility?
- Only if you are not ordering endotoxins on the same submission. Sterility and endotoxins can share one vial when ordered together.
- Is this suitable for research-use-only material?
- Yes. This workflow is designed for research peptide preparations—not retail or consumer products.